MANICKAM MURUGANANDHAM

TitleAssistant Professor
InstitutionMD Anderson
DepartmentRadiation Physics
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Netherton T, Li Y, Nitsch P, Shaitelman S, Balter P, Gao S, Klopp A, Muruganandham M, Court L. Interplay effect on a 6-MV flattening-filter-free linear accelerator with high dose rate and fast multi-leaf collimator motion treating breast and lung phantoms. Med Phys. 2018 Jun; 45(6):2369-2376. PMID: 29611210.
      Citations: 3     Fields:    Translation:Humans
    2. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 9570385.
      Citations:    Fields:    Translation:HumansCells
    3. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16704898.
      Citations: 1     Fields:    Translation:Cells
    4. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17125921.
      Citations: 2     Fields:    Translation:CellsPHPublic Health
    5. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15163811.
      Citations: 32     Fields:    Translation:Humans
    6. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15867253.
      Citations: 32     Fields:    Translation:AnimalsCells
    7. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20934275.
      Citations: 19     Fields:    Translation:Humans
    8. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17467897.
      Citations: 1     Fields:    Translation:CellsPHPublic Health
    9. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19665842.
      Citations: 1     Fields:    Translation:Cells
    10. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22988625.
      Citations: 3     Fields:    Translation:CellsPHPublic Health
    11. Muruganandham M, Zhang Y, Suri R, Lee GJ, Chen PK, Hsieh SH, Sillanpää M, Wu JJ. Environmental Applications of ZnO Materials. J Nanosci Nanotechnol. 2015 Sep; 15(9):6900-13. PMID: 26716262.
      Citations:    Fields:    
    12. Muruganandham M, Clerkin PP, Smith BJ, Anderson CM, Morris A, Capizzano AA, Magnotta V, McGuire SM, Smith MC, Bayouth JE, Buatti JM. 3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Sep 01; 90(1):181-9. PMID: 24986746.
      Citations: 21     Fields:    Translation:Humans
    13. Bhattarai B, Muruganandham M, Suri RP. Development of high efficiency silica coated ß-cyclodextrin polymeric adsorbent for the removal of emerging contaminants of concern from water. J Hazard Mater. 2014 May 30; 273:146-54. PMID: 24727017.
      Citations: 3     Fields:    Translation:CellsPHPublic Health
    14. Muruganandham M, Suri RP, Sillanpää M, Wu JJ, Ahmmad B, Balachandran S, Swaminathan M. Recent developments in heterogeneous catalyzed environmental remediation processes. J Nanosci Nanotechnol. 2014 Feb; 14(2):1898-910. PMID: 24749464.
      Citations: 2     Fields:    Translation:CellsPHPublic Health
    15. Muruganandham M, Sillanpää ME, Suri RP, Lee GJ, Wu JJ, Ahmad B, Kuroda Y. Fabrication and photocatalytic properties of self-assembled in(OH)3 and In2O3 nano/micro-cubes. J Nanosci Nanotechnol. 2013 Mar; 13(3):1639-48. PMID: 23755569.
      Citations:    Fields:    
    16. Schindel J, Muruganandham M, Pigge FC, Anderson J, Kim Y. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):387-93. PMID: 23433797.
      Citations: 13     Fields:    Translation:Humans
    17. Amutha R, Muruganandham M, Lee GJ, Wu JJ. Facile microwave-combustion synthesis of wurtzite CdS nanoparticles. J Nanosci Nanotechnol. 2011 Sep; 11(9):7940-4. PMID: 22097510.
      Citations: 1     Fields:    
    18. Jacobson G, Zamba G, Betts V, Muruganandham M, Buechler-Price J. Image-Based Treatment Planning of the Post-Lumpectomy Breast Utilizing CT and 3TMRI. Int J Breast Cancer. 2011; 2011:246265. PMID: 22295215.
      Citations: 4     
    19. Bayouth JE, Casavant TL, Graham MM, Sonka M, Muruganandham M, Buatti JM. Image-based biomarkers in clinical practice. Semin Radiat Oncol. 2011 Apr; 21(2):157-66. PMID: 21356483.
      Citations: 4     Fields:    Translation:Humans
    20. Amutha R, Akilandeswari S, Muruganandham M, Sillanpää M, Ahmmad B, Ohkubo T. Template-free synthesis of self-assembled Co3O4 micro/nanocrystals. J Nanosci Nanotechnol. 2011 Apr; 11(4):3171-9. PMID: 21776684.
      Citations:    Fields:    Translation:Cells
    21. Amutha R, Akilandeswari S, Ahmmad B, Muruganandham M, Sillanpää M. Template-free synthesis of beta-In2S3 superstructures and their photocatalytic activity. J Nanosci Nanotechnol. 2010 Dec; 10(12):8438-47. PMID: 21121351.
      Citations:    Fields:    
    22. Kalderon N, Muruganandham M, Koutcher JA, Potuzak M. Therapeutic strategy for acute spinal cord contusion injury: cell elimination combined with microsurgical intervention. PLoS One. 2007 Jul 18; 2(6):e565. PMID: 17637827.
      Citations: 8     Fields:    Translation:HumansAnimals
    23. Muruganandham M, Lupu M, Dyke JP, Matei C, Linn M, Packman K, Kolinsky K, Higgins B, Koutcher JA. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T. Mol Cancer Ther. 2006 Aug; 5(8):1950-7. PMID: 16928815.
      Citations: 21     Translation:HumansAnimals
    24. Muruganandham M, Swaminathan M. TiO2-UV photocatalytic oxidation of Reactive Yellow 14: effect of operational parameters. J Hazard Mater. 2006 Jul 31; 135(1-3):78-86. PMID: 16386844.
      Citations: 6     Fields:    Translation:Cells
    25. Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, Muruganandham M, Ebora L, Kattan MW, Reuter VE, Scardino PT, Koutcher JA. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology. 2005 Mar; 234(3):804-14. PMID: 15734935.
      Citations: 108     Fields:    Translation:Humans
    26. Muruganandham M, Koutcher JA, Pizzorno G, He Q. In vivo tumor lactate relaxation measurements by selective multiple-quantum-coherence (Sel-MQC) transfer. Magn Reson Med. 2004 Oct; 52(4):902-6. PMID: 15389963.
      Citations: 9     Fields:    Translation:Animals
    27. Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M, Sircar K, Kattan MW, Reuter VE, Scardino PT, Koutcher JA. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. Radiology. 2003 Oct; 229(1):241-7. PMID: 12920178.
      Citations: 47     Fields:    Translation:Humans
    28. Muruganandham M, Kasiviswanathan A, Jagannathan NR, Raghunathan P, Jain PC, Jain V. Diltiazem enhances tumor blood flow: MRI study in a murine tumor. Int J Radiat Oncol Biol Phys. 1999 Jan 15; 43(2):413-21. PMID: 10030270.
      Citations: 2     Fields:    Translation:Animals
    29. Erratum. Magnetic Resonance in Medicine. 53:491.
    MURUGANANDHAM's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (157)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _